Area riservata



Ipersensibilità allergica

Immunotherapy shows clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation
A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation...
Fonte: Immune System/Vaccines News From Medical News Today
 

Aggiungi commento



Aggiorna